Advanced search
Publication Cover
Current Medical Research and Opinion Volume 35, 2019 - Issue 10
Submit an article Journal homepage
705
Views
17
CrossRef citations to date
0
Altmetric
Pain

Efficacy and safety of mirogabalin for the treatment of fibromyalgia: results from three 13-week randomized, double-blind, placebo- and active-controlled, parallel-group studies and a 52-week open-label extension study

Lesley M. ArnoldWomen’s Health Research Program, University of Cincinnati College of Medicine, Cincinnati, OH, USA;
,
Susan WhitakerDaiichi Sankyo Inc., Basking Ridge, NJ, USA;
,
Ching HsuDaiichi Sankyo Inc., Basking Ridge, NJ, USA;
,
David JacobsDaiichi Sankyo Inc., Basking Ridge, NJ, USA;
&
Domenico MeranteGlobal Clinical Development, Daiichi Sankyo Development, Gerrards Cross, United KingdomCorrespondence[email protected]
Pages 1825-1835 | Received 01 Apr 2019, Accepted 04 Jun 2019, Published online: 09 Jul 2019

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.